Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04581395 · ClinicalTrials.gov registry record · Phase 3

The Effect of Pretreatment With Roc on Succinylcholine Myalgias

A Phase 3 study of Myalgia, sponsored by Indiana University.

Completed
Registry status
Phase 3
Development phase
300
Enrollment target
1
Study location

NCT04581395 is a Phase 3 study of Myalgia that has completed, run by Indiana University. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04581395, a Phase 3 study of Myalgia, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 3
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Succinylcholine is a medication (depolarizing muscle relaxant) that is used as part of an anesthetic (going to sleep for surgery). This medication can cause significant muscle soreness. Rocuronium is a medication (non-depolarizing muscle relaxant) that some anesthesia providers believe may reduce muscle soreness caused by succinylcholine if given prior, but this has been controversial. Some anesthesiologists pretreat patients with rocuronium before giving patients succinylcholine, and some do not. The purpose of this study is to examine the effect of pretreatment with rocuronium on muscle soreness associated with succinylcholine administration.

Conditions Studied

Interventions

  • OTHER non-pretreated Succinylcholine
  • DRUG succinylcholine 1 minute after rocuronium pretreatment
  • DRUG succinylcholine 2 minutes following rocuronium pretreatment

Study Locations (1)

Indiana

  • indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2020-10-02
Est. Completion 2023-04-25
Phase Phase 3

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT04581395

The ClinicalTrials.gov registry entry for NCT04581395 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myalgia appearing as the primary indexed condition, and to 3 interventions - of which non-pretreated Succinylcholine is the first listed.

NCT04581395 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT04581395 about?

NCT04581395 is a clinical study titled "The Effect of Pretreatment With Roc on Succinylcholine Myalgias". Succinylcholine is a medication (depolarizing muscle relaxant) that is used as part of an anesthetic (going to sleep for surgery). This medication can cause significant muscle soreness. Rocuronium is a medication (non-depolarizing muscle relaxant) that some anesthesia providers believe may reduce mu...

What is the current status of trial NCT04581395?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2020-10-02. Estimated completion is 2023-04-25.

What conditions does trial NCT04581395 study?

This clinical trial studies the following conditions: Myalgia.

What interventions are being tested in trial NCT04581395?

The interventions under investigation include: non-pretreated Succinylcholine (OTHER), succinylcholine 1 minute after rocuronium pretreatment (DRUG), succinylcholine 2 minutes following rocuronium pretreatment (DRUG).

Who is sponsoring clinical trial NCT04581395?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04581395 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.